AXGN

#4287
Axogen, Inc. - Common Stock
0.3 9 USD
-99.02%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.39
0.39
Range Annuel
0.39
45.75
Changement quotidien
-99.02%
Changement Mensuel
-99.07%
Evolution sur 6 mois
-98.64%
Changement Annuel
-97.84%
Clôture Précédente
40.4 2
Open
0.3 9
Low
0.3 9
High
0.3 9
Volume
121
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 20.99 M
  • Employee 622
  • Founded 2002
  • CEO N/A
  • Website www.axogeninc.com
  • Headquarter Minnesota, United States
  • FIGI BBG000BN46R9
  • Industry Dispositifs Médicaux
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-96.26
ratio cours/chiffre d'affaires
6.69

Axogen, Inc. - Common Stock

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

Nouvelles